Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Keeps Halo Pharma to drive independent growth
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
The company’s Growth Portfolio delivered $6.2 billion in revenue
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Subscribe To Our Newsletter & Stay Updated
